Role of progesterone and progesterone receptors in advanced endometrial cancer


Update content

Title Role of progesterone and progesterone receptors in advanced endometrial cancer
Period 01 / 2005 - unknown
Status Current
Research number OND1325592
Data Supplier Website EMC


In endometrial cancer, loss of progesterone receptors (PR) is associated with more advanced disease. This project aims to investigate the mechanism of action of progesterone and the loss of its receptors (PRA and PRB) in development of endometrial cancer. A 9600-cDNA microarray analysis was performed to study regulation of gene expression in the human endometrial cancer sub-cell line Ishikawa PRAB-36 by the progestagen medroxy progesterone acetate (MPA). Five MPA-regulated genes were selected for further investigation. Expression of these genes was studied by Northern blot and by immunohistochemistry in Ishikawa sub-cell lines expressing different PR isoforms. Additionally, endometrial cancer tissue samples were immunohistochemically stained to study the in vivo protein expression of the selected genes. In the PRAB-36 cell line, MPA was found to regulate the expression of a number of invasion- and metastasis-related genes. Upon further investigation of five of these genes (CD44, CSPG/Versican, Tenascin-C, Fibronectin-1, Integrin-b1), it was observed that expression and progesterone regulation of expression of these genes varied in sub-cell lines expressing different PR isoforms. Furthermore, in advanced endometrial cancer, it was shown that loss of expression of both PR and E-cadherin was associated with increased expression of CD44 and CSPG/Versican . The present study shows that progestagens exert a modulatory effect on the expression of genes involved in tumor cell invasion. As a consequence, loss of PR expression in human endometrial cancer may lead to development of a more invasive phenotype of the respective tumor.

Related organisations

Related people

Project leader L.J. Blok


D21400 Genetics
D21800 Immunology, serology
D23120 Oncology
D23220 Internal medicine

Go to page top
Go back to contents
Go back to site navigation